Can I read Nirmatrelvir-Ritonavir for Covid-19 Prophylaxis on EtoBox?

Nirmatrelvir-Ritonavir for Covid-19 Prophylaxis by Jose Macias is a document available to read on EtoBox.

What is Nirmatrelvir-Ritonavir for Covid-19 Prophylaxis about?

The study assessed the efficacy and safety of Nirmatrelvir–Ritonavir as postexposure prophylaxis for Covid-19 in household contacts of infected individuals. Results showed no significant reduction in symptomatic SARS-CoV-2 infection rates compared to placebo, with risk reductions of 29.8% for the 5-day and 35.5% for the 10-day regimens. While the treatment had a similar safety profile to placebo, it was not effective as prophylactic treatment in this trial.

Author

Jose Macias

Language

EN